Ocular Allergies: Comparing Safety and Efficacy of Therapies Including Immunotherapy-based Treatments

Login
Register
My Saved

My Account
Cart ()
Log Out
My Saved

Topics
Editorial Board
Educational Tools
Self-Assessment

Corneal/Conjunctivitis Disorders
Dry Eye Diagnostics
Dry Eye Therapeutics
Ocular Allergy
Ocular Infections
Ocular Surface Surgery

Editorial Board
Educational Tools
Self-Assessment

CME Information
Pretest
Ocular Allergies
Posttest
Evaluation

Home
Corneal/Conjunctivitis Disorders
Ocular Allergies: Comparing Safety and Efficacy of Therapies Including Immunotherapy-based Treatments

This activity is expired and is no longer available for CME credit.

CME Information
Pretest
Ocular Allergies
Posttest
Evaluation

This activity is supported by educational grants from Allergan, Inc. and Shire Pharmaceuticals.

Activity Contents

CME Information
Pretest
Ocular Allergies
Posttest
Evaluation

CME Information

EXPERT VIDEOCME

Ocular Allergies: Comparing Safety and Efficacy of Therapies Including Immunotherapy-based Treatments

Author(s)/Faculty: Douglas A. Katsev, MD
Release Date: 1/2/2018	Expiration Date: 1/1/2020
Credit Type: CME	Number of Credits: 0
Content Type: Video	Provider:
This CME will discuss the diagnosis and management of ocular allergies.

These continuing medical education activities are provided by

New to English? Translate here.

These continuing medical education activities are provided by

New to English? Translate here.

Overview

Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.

CME Information

Providership and Support

Provider Statement: This continuing medical education activity is provided by .

Support Statement: This activity is supported by educational grants from Allergan, Inc. and Shire Pharmaceuticals.

Target Audience and Learning Objective

Target Audience: The intended audience for the activity is ophthalmologists and other health care professionals involved in the treatment of patients with OSD.

Learning Objectives: Upon successful completion of this activity, participants should be better able to differentiate current therapeutic strategies for the treatment of ocular surface disorders to optimize therapy and improve patient outcomes.

Faculty and Disclosures

Chief Medical Editor:
Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC

Faculty:
Douglas A. Katsev, MD
Chair Ophthalmology
Sansum Clinic
Santa Barbara, CA

Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 1/11/2019)

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The author discloses that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Chief Medical Editor & faculty report the following relationship(s) which are accurate at the time of original content release (1/2/2018):
Terry Kim, MD
Consulting Fee: Acucela, Aerie, Alcon/Novartis, Allergan/Actavis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Ocunexus Therapeutics, Foresight, Kala, NovaBay, Ocular Therapeutix, Omeros, PowerVision, Presbyopia Therapies, Shire, SightLife Surgical, Simple Contacts, TearLab, TearScience
Ownership Interest: Kala, NovaBay, Ocular Therapeutix, Omeros, SightLife Surgical, Simple Contacts, TearScience

Douglas A. Katsev MD
Consulting Fee: Bausch + Lomb, Johnson & Johnson Vision, Omeros, Shire, Sun Pharmaceutical
Speakers Bureau: Bausch + Lomb, Johnson & Johnson Vision, Omeros, Shire, Sun Pharmaceutical
Ownership Interest: TrueVision

Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Credit Information

Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material was originally approved for 1 year from the date of original release, January 2, 2018 to January 1, 2019. It has since been recertified for an additional year and will now expire on January 1, 2020.

How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objective, answer the pretest question, view content, and complete the CME posttest and evaluation. Provide only one (1) answer for each question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Copyright and Questions

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?
Contact us at cme@vindicoCME.com